IDE Antibody / Insulin degrading enzyme
Selected Variant
RQ5434
Size: 100 µL
The IDE gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [RefSeq]
Product Specifications
CAS Number
9000-83-3
Specifications
Western blot: 1:500-1:2000
UniProt
P14735
Host
Rabbit
Reactivity
Human
Immunogen
A synthetic peptide specific to human Insulin-degrading enzyme / IDE was used as the immunogen for the IDE antibody.
Clonality
Monoclonal
Isotype
IgG
Clone
AOOB-9
Type
Recombinant
Applications
WB
Purity
Affinity purified
Format
Purified
Buffer
Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5mg/ml BSA
Reconstitution
Store the IDE antibody at -20oC.
Limitations
This IDE antibody is available for research use only.
Storage Conditions
Store the IDE antibody at -20°C.
Formulation
Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5 mg/mL BSA
Applications Notes
Optimal dilution of the IDE antibody should be determined by the researcher.
Image Legend
Western blot testing of human HepG2 cell lysate with IDE antibody. Predicted molecular weight ~118 kDa.
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog